Medicare Prescription Costs To Rise

TS-Si is dedicated to the acceptance, medical treatment, and legal protection of individuals correcting the misalignment of their brains and their anatomical sex, while supporting their transition into society as hormonally reconstituted and surgically corrected citizens.

SciMed - Healthcare

TS-Si News Service

Friday, 21 April 2006 13:08

Beneficiaries Face Increases Next Year

The six million poorest beneficiaries may pay as much as seven percent more next year for the new U.S. Medicare prescription drug benefit.

While these beneficiaries have no annual co-payment and don't have to contend with a coverage gap, their co-payments for generic drugs will increase from $2 to $2.15 and from $5 to $5.35 for brand-name drugs, the Los Angeles Times reported.

These increases may seem small, but many state-sponsored Medicaid plans previously charged no co-payments. These Medicare co-payments may prove too much of a burden for low-income people who require 10 or more prescription drugs, say independent experts and state officials.

These and other cost increases were included when the new prescription drug plan was designed, the Times reported. Congress decided to index the share paid by beneficiaries to yearly increases in prescription drug spending.

< Prev		Next >

Last Updated on Monday, 27 August 2007 16:00

Add comment

TS-Si often publishes material that presents challenges and insights worthy of extended discussion. We encourage lively, open debate and ask that you show respect for others with responsible comments. This can be done with emotional maturity and intelligence. Before commenting, please thoroughly read the article and other comments, then stay on topic. Address the issues without presumptions about the author(s) or other persons.

We will remove any comment that is a personal attack or off-topic, abusive, exceptionally incoherent, libelous, mysogonist, obscene, phobic, profane, racist, or otherwise inappropriate. Removal for cause may occur without prior notice and repeat offenders may lose commenting privileges. These abuses and/or any attempt to post a solicitations and/or advertising, flood, spam, or otherwise disrupt TS-Si.org operations are subject to further sanctions.

All comments are subject to our terms of use and overall site policies, available under the About menu tab.

JComments

TS-Siis dedicated to the acceptance, legal protection, and medical treatment of individuals correcting the misalignment of their brains and their anatomical sex, while supporting their transition into society as hormonally reconstituted and surgically corrected citizens.

We welcome responsible comments. Use the public article forms throughout this site or send private correspondence via the TS-Si Contact Page. We will not divulge personal details or place you on a mailing list without your permission.

The TS-Si News Service and the TS-Si Research Service are collaborations of TS-Si officials, staff, contributors, and corresponding institutions. The contents do not necessarily convey official positions of TS-Si or its owners, participants, partners, or affiliates.

Except as explicitly noted in specific cases, works on this TS-Si.org website are licensed under a Creative Commons Attribution-No Derivative Works 3.0 Unported License. Copyright © 2005-2011 TS-Si, Inc. Some rights reserved.